Whole Exome Sequencing (Hongkung) at Chughtai Lab

Whole Exome Sequencing (Hongkung) at Chughtai Lab

Whole Exome Sequencing (WES) represents one of the most advanced frontiers in molecular diagnostics and genomic medicine. At Chughtai Lab, Pakistan’s premier diagnostic network, the Whole Exome Sequencing (Hongkung) test offers an unparalleled, comprehensive analysis of the protein-coding regions of the human genome. While the exome constitutes only about 1% to 2% of the entire genome, it contains approximately 85% of all known disease-causing mutations. This makes WES an incredibly high-yield diagnostic tool for identifying the underlying genetic causes of complex, rare, and undiagnosed medical conditions. By utilizing state-of-the-art Next-Generation Sequencing (NGS) technology and sophisticated bioinformatics pipelines, Chughtai Lab provides clinicians and patients across Pakistan with deep genomic insights that are crucial for precise diagnosis, prognosis, and personalized treatment planning.

The “Hongkung” designation refers to a specialized, high-throughput sequencing protocol and collaborative bioinformatics pipeline optimized for clinical-grade accuracy. This advanced molecular test analyzes over 20,000 genes simultaneously, searching for single nucleotide variants (SNVs), small insertions or deletions (indels), and other genetic alterations that lead to functional changes in essential proteins. For patients who have undergone a long and exhausting diagnostic odyssey—visiting multiple specialists and undergoing numerous inconclusive tests—Whole Exome Sequencing at Chughtai Lab offers a definitive path toward answers. It is particularly valuable in pediatric neurology, developmental medicine, metabolic disorders, and complex multi-system syndromes where clinical presentations are highly atypical or genetically heterogeneous.

Clinical Procedure: What to Expect

Patient Preparation

Because Whole Exome Sequencing is a highly specialized genetic test, proper preparation is essential to ensure clinical utility and accurate interpretation of the genomic data. Patients and their families should observe the following preparation guidelines:

• Clinical Documentation: A detailed clinical history, including a comprehensive referral letter from the attending physician, specialist, or clinical geneticist, is mandatory.
• Pedigree Charting: Providing a detailed three-generation family history or pedigree chart helps the laboratory’s bioinformaticians contextualize identified genetic variants.
• Informed Consent: Genetic counseling and signed informed consent are required prior to sample collection. This process ensures that the patient or legal guardian understands the implications of genetic testing, including the potential discovery of secondary or incidental findings.
• No Fasting Required: There are no dietary restrictions or fasting requirements for this test. Patients can eat and drink normally before sample collection.
• Medication Status: Routine medications do not interfere with genomic DNA sequencing and should be continued as prescribed by the physician.

During the Procedure

The technical execution of the Whole Exome Sequencing (Hongkung) test at Chughtai Lab involves several highly controlled laboratory and analytical steps:

• Sample Collection: A simple peripheral blood sample (usually 3 to 5 mL in an EDTA tube) is collected by a trained phlebotomist. In pediatric or specialized cases, alternative samples such as saliva or buccal swabs may be utilized if validated.
• DNA Extraction: In the molecular biology laboratory, high-purity genomic DNA is extracted from the patient’s white blood cells using automated extraction platforms to ensure maximum yield and integrity.
• Library Preparation and Target Enrichment: The extracted DNA is fragmented, and specialized molecular probes are used to capture and enrich only the exonic (protein-coding) regions of the genome, preparing them for sequencing.
• Next-Generation Sequencing (NGS): The enriched DNA library is loaded onto high-throughput sequencing platforms, where millions of DNA fragments are sequenced in parallel, generating massive amounts of raw genetic data.
• Bioinformatics Analysis: Advanced computational algorithms align the sequenced fragments against the human reference genome. Specialized software filters and identifies variants, comparing them against global genomic databases.
• Clinical Interpretation: A team of qualified molecular pathologists and clinical geneticists reviews the filtered variants, correlating them directly with the patient’s specific clinical symptoms and family history to identify pathogenic or likely pathogenic mutations.

When is a Whole Exome Sequencing (Hongkung) Test Performed?

Developmental Delay and Intellectual Disability

Physicians frequently request Whole Exome Sequencing for pediatric patients presenting with unexplained global developmental delay or intellectual disability. When standard developmental milestones are significantly missed and initial metabolic or chromosomal microarray tests yield normal results, WES serves as a powerful diagnostic tool. It can identify specific monogenic causes of cognitive impairment, allowing families to understand the underlying etiology, access targeted therapeutic interventions, and receive accurate recurrence risk counseling for future pregnancies.

Unexplained Neurological and Neuromuscular Symptoms

Progressive neurological decline, early-onset refractory seizures, intractable epilepsy, severe hypotonia, or unexplained muscle weakness often prompt specialists to order WES. Many neurological disorders have overlapping clinical features but distinct genetic origins. By sequencing the entire exome, Chughtai Lab can pinpoint mutations in ion channels, structural muscle proteins, or neuronal metabolic pathways, helping neurologists differentiate between conditions like muscular dystrophies, congenital myasthenic syndromes, or genetic epilepsies.

Suspected Inborn Errors of Metabolism

Inborn errors of metabolism (IEM) encompass a diverse group of rare genetic disorders where single-gene mutations disrupt normal metabolic pathways. Symptoms can range from acute metabolic crises in newborns to progressive organ damage in older children. When routine biochemical screens suggest a metabolic defect but cannot isolate the specific enzyme deficiency, Whole Exome Sequencing provides a comprehensive look at all genes encoding metabolic enzymes, facilitating rapid, life-saving dietary or medical management.

Multiple Congenital Anomalies

Infants born with multiple structural abnormalities affecting different organ systems—such as congenital heart defects, skeletal dysplasias, craniofacial dysmorphism, and renal anomalies—frequently require exome sequencing. Because these complex phenotypes can be caused by mutations in a wide array of developmental genes, sequencing the entire exome is far more efficient and cost-effective than testing individual genes sequentially, leading to a much faster clinical diagnosis.

Family History of Undiagnosed Genetic Conditions

When a family has a history of recurrent, undiagnosed childhood illnesses, early deaths, or hereditary disorders of unknown cause, Whole Exome Sequencing is highly indicated. Identifying the specific genetic variant responsible for the condition within the family allows other asymptomatic family members to undergo targeted carrier testing. It also enables prenatal diagnosis or pre-implantation genetic testing in future pregnancies, offering vital reproductive options to affected families.

What Does a Whole Exome Sequencing (Hongkung) Test Detect?

Whole Exome Sequencing is designed to detect a wide spectrum of genetic variations across approximately 20,000 protein-coding genes. Specifically, this comprehensive molecular analysis detects:

• Pathogenic single nucleotide variants (SNVs) that alter critical amino acids in essential proteins.
• Small insertions or deletions (indels) that cause frameshift mutations, leading to non-functional or truncated proteins.
• Nonsense mutations that introduce premature stop codons, halting protein synthesis.
• Splice-site mutations that disrupt the precise splicing of pre-mRNA, altering the final protein structure.
• Genetic variants associated with autosomal dominant, autosomal recessive, and X-linked hereditary disorders.
• De novo mutations (new mutations present in the patient but not inherited from either parent).
• Variants of Uncertain Significance (VUS) that require careful clinical correlation and potential parental testing to clarify their clinical relevance.
• Incidental or secondary findings in medically actionable genes, such as those associated with hereditary cancer syndromes (e.g., BRCA1, BRCA2) or familial cardiomyopathies, in accordance with international clinical genetics guidelines.
• Genetic causes of rare syndromic and non-syndromic forms of hearing loss, vision impairment, and skeletal dysplasias.
• Mutations in genes responsible for primary immunodeficiencies, rendering patients highly susceptible to recurrent, severe infections.

Turnaround Time and Report Access at Chughtai Lab

Due to the immense complexity of sequencing millions of DNA base pairs, performing rigorous bioinformatics filtering, and conducting expert clinical interpretation, Whole Exome Sequencing is a highly detailed process. At Chughtai Lab, the turnaround time for the Whole Exome Sequencing (Hongkung) test typically ranges from 4 to 6 weeks. This timeline ensures that every identified variant is thoroughly analyzed, verified, and cross-referenced with the latest medical literature and clinical databases. Once the comprehensive genomic report is finalized by our specialist molecular pathologists, patients and their referring physicians can access the detailed reports online through the secure Chughtai Lab web portal or the user-friendly Chughtai Lab mobile application, facilitating prompt clinical consultation and decision-making.

Whole Exome Sequencing Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Coding Regions (Exons)	Sequence matching standard human reference genome without disease-causing alterations.	Detection of pathogenic single nucleotide variants (SNVs) or small indels in disease-associated genes.
Splice Junctions	Conserved splice-site sequences ensuring accurate mRNA splicing and protein translation.	Splice-site mutations leading to exon skipping, intron retention, or aberrant protein isoforms.
Mendelian Disease Genes	No pathogenic or likely pathogenic variants identified in genes linked to known genetic disorders.	Identification of homozygous, heterozygous, or compound heterozygous mutations causing genetic disease.
Variant Classification	Only benign or likely benign variants, which represent normal human genetic diversity.	Identification of Pathogenic (Class 5) or Likely Pathogenic (Class 4) variants explaining the clinical phenotype.
Variants of Uncertain Significance (VUS)	No ambiguous variants detected in genes directly correlating with the patient’s primary symptoms.	Presence of a VUS (Class 3) requiring further clinical correlation, segregation analysis, or parental testing.
Secondary / Incidental Findings	No actionable pathogenic variants in genes unrelated to the primary indication (if patient opted in).	Detection of pathogenic variants in actionable genes (e.g., hereditary cancers, cardiovascular risk genes).
Sequence Coverage & Quality	High-depth coverage (typically >100x) across >98% of target exonic regions, ensuring analytical validity.	Localized low coverage in highly GC-rich or repetitive regions, occasionally requiring alternative sequencing methods.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for Whole Exome Sequencing?

• Experienced Healthcare Professionals: Our molecular diagnostics division is led by highly qualified pathologists, molecular biologists, and clinical geneticists with extensive training in genomic interpretation.
• Patient-Focused Care: We provide comprehensive support throughout the testing process, emphasizing clear communication, informed consent, and compassionate patient care.
• Quality Diagnostic Services: Chughtai Lab adheres to stringent international quality control standards, ensuring the highest level of analytical accuracy and clinical reliability.
• Professional Reporting: Our genomic reports are structured, detailed, and clinically oriented, providing clear classifications of variants to assist clinicians in direct patient management.
• Modern Diagnostic Approach: We utilize advanced Next-Generation Sequencing (NGS) technologies and state-of-the-art bioinformatics pipelines to deliver cutting-edge genomic insights.
• Comfortable Environment: Our nationwide network of diagnostic centers offers a welcoming, professional, and hygienic environment for all patient interactions and sample collections.
• Convenient Location: With hundreds of collection centers across Pakistan and a robust home sampling service, accessing advanced genetic testing has never been easier.
• Commitment to Accurate Diagnosis: We are dedicated to helping patients resolve complex diagnostic dilemmas by delivering precise, evidence-based genetic answers.